Send PM
Followers 3
Posts 89
Boards Moderated 0
Alias Born 08/12/2022

FREE
ABBV REPORT

Re: None

Wednesday, 08/17/2022 6:05:57 AM

Wednesday, August 17, 2022 6:05:57 AM

Post# of 723

Imbruvica (ibrutinib) Pharmacyclics (AbbVie)
2021 Sales $9,777,000,000.00


Data was excellent. Doubled CR of (ABBV) ibrutinib alone in MCL

Data in P53 mutant CCL is game changing

ABBV Let this sink in on how valuable this combo is $$$ for ABBV

Two ROR1 acquisitions Merck acquired early clinical data VelsoBio.. for $2.8 Billion & Boehringer buys NBE Therapeutics $1.5Billion ROR1 deal last year.


$ONCT

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News